OpenLobby.EU
Explore

European Society of Gyneacological Oncology

ESGO

Founded in 1983, the European Society of Gynaecological Oncology (ESGO) is a growing not-for profit organisation and forum of more than 3,000 professionals from across Europe and all around the world, dedicated to promoting the highest quality of care for women with gynaecological cancers.

Lobbying Activity

Meeting with Philippe Roux (Head of Unit Health and Food Safety) and Incisive Health and Unknown Organization

7 Jan 2026 · EGSO position paper’s scope and preliminary recommendations

Response to Gender Equality Strategy 2026-2030

8 Aug 2025

ESGOs infrastructure to support womens health The European Society of Gynaecological Oncology (ESGO) welcomes the opportunity to contribute to the European Commissions consultation on the post-2025 EU Gender Equality Strategy. As a leading scientific society advancing women's cancer care in Europe, ESGO strongly believes that gender equality cannot be achieved without targeted investment in womens health. Gynaecological cancers are a striking example of the persistent gaps and inequalities that women continue to face across Europe. Addressing these disparities requires systemic solutions that go beyond individual actions. Through its pan-European infrastructure of accredited centres, structured training programmes, and cross-border research initiatives, ESGO has developed a model of care that improves quality, equity, and outcomes in womens health. Based on this experience, ESGO calls for the creation of an EU-wide Ecosystem of Centres of Excellence for Womens Health, integrated into the broader EU policy framework. Such an initiative would also act as a structural enabler of the eight pillars of the Gender Equality Strategy, from improving womens participation in research and decision-making, to ensuring fairer working conditions and access to care. Health is the foundation of equality. Ensuring womens access to high-quality, evidence- based, and person-centred healthcare must be a central component of the EUs efforts to advance gender equality beyond 2025. For more detailed recommendations, we invite you to consult our full contribution, attached to this submission.
Read full response